Application | Comment | Organism |
---|---|---|
drug development | the essential nature of the enzymes makes it an attractive targets for designing of drugs against important pathogenic protozoans like Toxoplasma | Toxoplasma gondii |
Cloned (Comment) | Organism |
---|---|
recombinant expression of His6-tagged wild-type full-length enzyme and truncated mutant enzymes in Escherichia coli strain BL21(DE3), optimization of expression conditions | Toxoplasma gondii |
Crystallization (Comment) | Organism |
---|---|
purified recombinant His-tagged N-terminal and C-terminal domain fragments, sitting drop vapour diffusion method, mixing of 20 mg/ml protein in 25 mM Tris pH 7.5, 150 mM KCl, and 10 mM MgCl2, with 2 M ammonium sulfate, 5% isopropanol for the N-terminal fragment and 2 M ammonium sulfate for the C-terminal fragment, X-ray diffraction structure determination and analysis. No crystallization conditions can be identified for the full-length protein | Toxoplasma gondii |
Protein Variants | Comment | Organism |
---|---|---|
additional information | construction of a C-terminal catalytic domain (QRS-C) of the QRS gene, a region corresponding to residues 255-805 of the annotated full-length gene, and of an N-terminal domain contruct | Toxoplasma gondii |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Toxoplasma gondii |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-glutamine + tRNAGln | Toxoplasma gondii | - |
AMP + diphosphate + L-glutaminyl-tRNAGln | - |
? | |
ATP + L-glutamine + tRNAGln | Toxoplasma gondii ATCC 50611 / Me49 | - |
AMP + diphosphate + L-glutaminyl-tRNAGln | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Toxoplasma gondii | A0A125YXL3 | - |
- |
Toxoplasma gondii ATCC 50611 / Me49 | A0A125YXL3 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant His6-tagged wild-type full-length enzyme and truncated mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity chromatography, ultrafiltration, and gel filtration, optimization of purification conditions | Toxoplasma gondii |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-glutamine + tRNAGln | - |
Toxoplasma gondii | AMP + diphosphate + L-glutaminyl-tRNAGln | - |
? | |
ATP + L-glutamine + tRNAGln | - |
Toxoplasma gondii ATCC 50611 / Me49 | AMP + diphosphate + L-glutaminyl-tRNAGln | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Glutaminyl-tRNA synthetase | - |
Toxoplasma gondii |
QRS | - |
Toxoplasma gondii |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Toxoplasma gondii |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Toxoplasma gondii |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Toxoplasma gondii |